Apogee Therapeutics Inc. is a clinical-stage biotechnology company developing differentiated biologics for inflammatory and immune diseases. It focuses on advancing novel antibody therapeutics targeti... Apogee Therapeutics Inc. is a clinical-stage biotechnology company developing differentiated biologics for inflammatory and immune diseases. It focuses on advancing novel antibody therapeutics targeting well-established biological drivers to address conditions with high unmet needs, including atopic dermatitis, chronic obstructive pulmonary disease, asthma, and other dermatological, respiratory, and gastroenterological disorders. The company's pipeline aims to improve treatment standards by optimizing antibodies for potentially superior efficacy and reduced dosing frequency compared to existing options. Apogee Therapeutics Inc. emphasizes creating therapies that enhance patient lives through innovative approaches in immunology. Its team consists of experienced clinical, commercial, scientific, and operational leaders committed to excellence in drug development. Headquartered in Waltham, Massachusetts, and founded in 2022, the company operates in the biotech sector dedicated to reshaping care for immune-mediated diseases.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Apogee Therapeutics is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Apogee Therapeutics is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Apogee Therapeutics's data?

Start your 30-day free trial to request a data review for Apogee Therapeutics.

Start Free Trial

Legal Center Contact Us